Skip to main content
. 2016 Jun 14;7(27):40992–41004. doi: 10.18632/oncotarget.10038

Figure 2.

Figure 2

Prognostic impact of A. total CD8+ TILs and B. total PD-1+ TILs on overall survival (OS), progression-free survival (PFS), local progression-free survival (LPFS) and distant metastases free survival (DMFS) in in patients with pancreatic cancer adenocarcinoma, as indicated. Analysis was based on the dichotomized total CD8 and PD-1 score in resected patient samples (cut-off according to median value of total score).